Repaglinide is mainly used to treat type II diabetes mellitus in which diet control, weight reduction and exercise cannot effectively control high blood sugar.
Repaglinide is a fast-acting, short-acting insulin-secretion-stimulating mealtime glycemic regulator. Its mechanism of action is mainly by closing the potassium channels on the β cell membrane, causing calcium ion influx, increasing the concentration of calcium ions in cells, thereby stimulating insulin secretion. However, it is different from the receptor site of sulfonylurea drugs, and the drug does not enter β cells, does not inhibit protein synthesis or directly causes exocytosis of insulin.
|Appearance||White or almost white crystalline powder||White solid|
|Residue on ignition||≤0.1%||0.05%|
|Loss on drying||≤0.7%||0.23%|
|Assay||98.0% - 102.0%||99.88%|
|Appearance:||White or almost white crystalline powder|
|Purity:||98.0% - 102.0%|
|Package details:||500g/bag;1kg/bag or as you require|
Guaranteed the purity
High quality & competitive price
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!